The promising potential of terapia con cellule staminali has given rise to initially encouraging clinical results. While doctors in North America and Western Europe continue to study terapia con cellule staminali, rigorously evaluating its potential benefits, necessity triggered application of this science in clinical practice in Ukraine almost 20 twenty years ago. Nearly a million people in the Kiev area alone experienced adverse health effects when radioactive dust settled across Ukraine following the nuclear reactor explosion at Chernobyl in April 1986. Faced with treating patients suffering from conditions ranging from diabetes to blood anemia and cancer, the Ukrainian government began funding new research into repairing tissue and blood cells that would produce results quickly. Doctors turned to adult terapia con cellule staminali, and they claim to have been successfully treating patients there since the Chernobyl disaster. Scientists in other countries are skeptical about this success because there are no published random clinical trials – the gold standard of medical research – regarding the positive or negative effects of terapia con cellule staminali. Many countries have banned some forms of stem cell research, while scientists in other countries strive to become leaders in this controversial area of exploration.
Terapia con cellule staminali
Terapia con cellule staminali per il fegato
I pazienti affetti da cirrosi scompensata devono per lo più optare per il trapianto di fegato, ma la disponibilità limitata di organi da donatori e i costi elevati comportano un’elevata mortalità in lista d’attesa . Le cellule staminali del proprio corpo aiutano Per saperne di più…